Get started
MEDIFAST INCMEDIFAST INCMEDIFAST INC

MEDIFAST INC

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsOptionsETFs
Full chart
Full chart

Compare with MEDIFAST INC



Key stats


Market capitalization
‪128.35 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.33 USD
Net income (FY)
‪−18.67 M‬ USD
Revenue (FY)
‪385.79 M‬ USD
Shares float
‪10.48 M‬
Beta (1Y)
1.85

Latest earnings


Last report date
Aug 3, 2026
Report period
Q2 2026
EPS
−0.28 USD
Revenue
‪76.38 M‬ USD
Earnings call summary

Revenue stabilized sequentially, with coach productivity up 41% year-over-year despite a 48.7% drop in active coaches. Q2 revenue was $76.4 million, net loss $3.1 million, and profitability is targeted for Q4 2026, supported by new product launches and cost-saving initiatives.

Employees


Employees (FY)
380
Change (1Y)
−124−24.60%
Revenue / Employee (1Y)
‪1.02 M‬ USD
Net income / Employee (1Y)
‪−49.14 K‬ USD

Details


Sector
Commercial Services
Industry
Miscellaneous Commercial Services
CEO
Nicholas M. Johnson
Website
medifastinc.com
Headquarters
Baltimore
Founded
1980
IPO date
Dec 30, 1993
ISIN
US58470H1014
CUSIP
58470H101
FIGI
BBG000BWBW76
Identifiers
ISIN US58470H1014
CFI code
ESVUFR
Medifast, Inc. is a health and wellness company, which engages in the provision of habit-based and coach-guided lifestyle solutions called OPTAVIA. It offers and ships OPTAVIA products directly to its customers. It focuses on coaching healthy habits through a health transformational system. The company was founded by William Vitale in 1980 and is headquartered in Baltimore, MD.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


AVUV
Avantis U.S. Small Cap Value ETF
Weight0.01%
Market value‪3.85 M‬
FNDA
Schwab Fundamental U.S. Small Company ETF
Weight0.03%
Market value‪2.96 M‬
SMLF
iShares U.S. Small-Cap Equity Factor ETF
Weight0.03%
Market value‪1.41 M‬
DFSV
Dimensional US Small Cap Value ETF
Weight0.01%
Market value‪695.95 K‬
BSVO
EA Bridgeway Omni Small-Cap Value ETF
Weight0.02%
Market value‪588.14 K‬
IWC
iShares Microcap ETF
Weight0.03%
Market value‪425.83 K‬
FSCC
Federated Hermes MDT Small Cap Core ETF
Weight0.11%
Market value‪365.19 K‬
BUSM
EA Bridgeway Ultra-Small Company Market ETF
Weight0.09%
Market value‪114.80 K‬
CAUV
Avantis CIBC U.S. Small Cap Value ETF Common Units Trust Units
Weight0.00%
Market value263.82

Explore more ETFs 

Frequently asked questions


The current price of MED is 11.44 USD — it has decreased by −0.35% in the past 24 hours. Watch MEDIFAST INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange MEDIFAST INC stocks are traded under the ticker MED.
MED stock has fallen by −6.46% compared to the previous week, the month change is a 7.32% rise, over the last year MEDIFAST INC has showed a −14.69% decrease.
We've gathered analysts' opinions on MEDIFAST INC future price: according to them, MED price has a max estimate of 12.00 USD and a min estimate of 12.00 USD. Watch MED chart and read a more detailed MEDIFAST INC stock forecast: see what analysts think of MEDIFAST INC and suggest that you do with its stocks.
MED reached its all-time high on May 28, 2021 with the price of 336.99 USD, and its all-time low was 0.09 USD and was reached on Dec 23, 1999. View more price dynamics on MED chart.
See other stocks reaching their highest and lowest prices.
MED stock is 2.24% volatile and has beta coefficient of 1.85. Track MEDIFAST INC stock price on the chart and check out the list of the most volatile stocks — is MEDIFAST INC there?
Today MEDIFAST INC has the market capitalization of ‪128.35 M‬, it has decreased by −0.10% over the last week.
Yes, you can track MEDIFAST INC financials in yearly and quarterly reports right on TradingView.
MEDIFAST INC is going to release the next earnings report on Nov 9, 2026. Keep track of upcoming events with our Earnings Calendar.
MED earnings for the last quarter are −0.28 USD per share, whereas the estimation was −0.65 USD resulting in a 56.92% surprise. The estimated earnings for the next quarter are −0.35 USD per share. See more details about MEDIFAST INC earnings.
MEDIFAST INC revenue for the last quarter amounts to ‪76.38 M‬ USD, despite the estimated figure of ‪72.70 M‬ USD. In the next quarter, revenue is expected to reach ‪71.30 M‬ USD.
MED net income for the last quarter is ‪−3.10 M‬ USD, while the quarter before that showed ‪−2.12 M‬ USD of net income which accounts for 0.00% change. Track more MEDIFAST INC financial stats to get the full picture.
As of Aug 15, 2026, the company has 380 employees. See our rating of the largest employees — is MEDIFAST INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDIFAST INC EBITDA is ‪−3.46 M‬ USD, and current EBITDA margin is −0.96%. See more stats in MEDIFAST INC financial statements.
Like other stocks, MED shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDIFAST INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDIFAST INC technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDIFAST INC stock shows the sell signal. See more of MEDIFAST INC technicals for a more comprehensive analysis.